Enabling effective anti-tumor immunity from targeted antibodies through dual innate and adaptive immune checkpoint blockade in non-immunogenic cancers
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
National Cancer Institute
Start Date
December 6, 2019
End Date
November 30, 2024
Administered By
Surgery, Surgical Sciences
Awarded By
National Cancer Institute
Start Date
December 6, 2019
End Date
November 30, 2024